Expand ALLO Menu
ALLO MENU

ALLO Stock Posts


Upcoming Earnings

ALLO Allogene Therapeutics2.49-0.14 (-5.3%)

Allogene Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±19.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±8.4%. View Expected Move (Conf Call: Mar 12 5:00 PM)
Unusual Option Volume

ALLO Allogene Therapeutics2.43-0.10 (-4.0%)

Allogene Therapeutics trades 2,536 contracts. The highest volume is in the 20-Mar-26 2.5 calls, which is 2.9% above the current price.
Unusual Option Volume

ALLO Allogene Therapeutics2.12+0.32 (+17.8%)

Allogene Therapeutics trades 3,008 contracts. The company has the following event: Citi's 2026 Virtual Oncology Leadership Summit on Feb 18, 2026.
Unusual Option Volume

ALLO Allogene Therapeutics1.65-0.05 (-2.9%)

Allogene Therapeutics trades 2,640 contracts. The highest volume is in the 16-Jan-26 1.5 puts.
Upcoming Earnings

ALLO Allogene Therapeutics1.08-0.03 (-2.7%)

Allogene Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±22.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.2%. View Expected Move (Conf Call: Nov 6 5:00 PM)
Upcoming Earnings

ALLO Allogene Therapeutics1.05+0.02 (+1.9%)

Allogene Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±8.9% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.6%. View Expected Move (Conf Call: Aug 13 5:00 PM)
Market Data Delayed 15 Minutes